MiNK Therapeutics Inc.
0.86
0.01 (1.18%)
At close: Jan 15, 2025, 3:59 PM
0.87
0.60%
After-hours Jan 15, 2025, 04:00 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19
PE Ratio -1.64 -3.55 -6.46 -25.32 -15.32
PS Ratio n/a 0.03 n/a n/a 575.74
PB Ratio -2.04 -219 6.28 -7.37 -10.93
P/FCF Ratio -2.32 -4.6 -11.42 -47.08 -25.83
P/OCF Ratio -2.33 -4.66 -11.64 -47.62 -26.57
OCF/S Ratio n/a -0.01 n/a n/a -21.67
Debt / Equity Ratio n/a n/a n/a -0.81 -0.74
Quick Ratio 0.32 1.61 2.41 0.22 0.11
Current Ratio 0.32 1.61 2.41 0.29 0.12
Asset Turnover n/a 125.97 n/a n/a 0.53
Interest Coverage n/a -122.17 -11.66 -6 -14.28
Return on Equity (ROE) 1.24 61.75 -0.97 0.29 0.71
Return on Assets (ROA) -4.93 -1.15 -0.57 -3.44 -19.8
Return on Capital (ROIC) 3.35 -3.52 -1.19 1.51 3.65
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin n/a -1.04K% n/a n/a 100.00%
Net Profit Margin n/a -0.92% n/a n/a -3.76K%
Pretax Profit Margin n/a -1.03% n/a n/a -3.45K%
Operating Profit Margin n/a -1.14% n/a n/a -3.23K%
FCF Margin n/a -0.71% n/a n/a -2.23K%
EBITDA Margin n/a -1.14% n/a n/a -3.22K%